IP Library Assignment 064813/0141
Patent Assignment
Reel/Frame 064813/0141

Assignment of Assignor's Interest

Recorded: 2023-09-06 Pages: 19
Assignor
SHIRE VIROPHARMA LLC
Executed: 2021-03-31
Assignee
TAKEDA PHARMACEUTICAL COMPANY LIMITED
1-1, DOSHOMACHI 4-CHOME, CHUO-KU, OSAKA-SHI, OSAKA, 541-0045, JAPAN
Covered Property (1)
Crystalline Phases of 5,6-Dichloro-2-(Isopropylamino)-(1 Beta-L-Ribofuranosyl)-1H-Benzimidazole
Application: 17/481,980 →
Publication: US 2022/0372059
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 6, 2023
From: COQUEREL, GERARD; LEVILAIN, GUILLAUME; PETIT, MARIE-NOELLE; COSTE-LECONTE, SERVANTE
To: VIROPHARMA INCORPORATED
Reel/Frame 064813/0028 →
Change of Name Sep 6, 2023
From: VIROPHARMA INCORPORATED
To: SHIRE VIROPHARMA INCORPORATED
Reel/Frame 064818/0659 →
Change of Name Sep 6, 2023
From: SHIRE VIROPHARMA INCORPORATED
To: SHIRE VIROPHARMA LLC
Reel/Frame 064818/0663 →